Health Equity: 09/29/08

Monday, September 29, 2008

[EQ] Pharmaceutical Pricing Policies in a Global Market

Pharmaceutical Pricing Policies in a Global Market

OECD Health Policy Studies - Directorate for Employment, Labour and Social Affairs, Health Division
September 2008

Pharmaceutical pricing policies are designed with national objectives in mind, but are the transnational implications always taken into account?

Executive summary: http://www.oecd.org/dataoecd/36/2/41303903.pdf

OECD website: http://www.oecd.org/document/36/0,3343,en_2649_33929_41000996_1_1_1_37407,00.html

“….This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives. It examines the national and transnational effects of these policies, in particular, their implications for the availability of medicines in other countries, the prices of these medicines, and innovation in the pharmaceutical sector.

This publication presents an analysis of comparative price levels, making use of a unique dataset to construct the most comprehensive pan-OECD pharmaceutical price index to date. It also draws upon original case studies of pharmaceutical pricing and reimbursement policies in six OECD countries to provide specific examples of the impacts of policies on health system performance The latest comparable data and trends on different aspects of the performance of health systems in OECD countries….”

Table of Contents

Executive Summary
Introduction
Chapter 1. Key Characteristics of the Pharmaceutical Sector in OECD Economies

Chapter 2. The Pharmaceutical Industry and its Activities

Chapter 3. Pharmaceutical Pricing and Reimbursement and the Broader Pharmaceutical Policy

Chapter 4. The Impact of Pharmaceutical Pricing Policies on Performance in Meeting Health Policy Goals

Chapter 5. The Impact of National Pricing and Reimbursement Practices on Prices and Availability of Medicines in Other Countries

Chapter 6. The Impact of Pharmaceutical Pricing Policies on Pharmaceutical Innovation

* * *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues. [DD/ KMS Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.

[EQ] Will It Work Here? A Decision maker's Guide to Adopting Innovations

Will It Work Here? A Decision maker’s Guide to Adopting Innovations

Agency for Healthcare Research and Quality -U.S. Department of Health and Human Services

RTI International for the Agency for Healthcare Research and Quality - AHRQ Publication No. 08-0051 September 2008

Available online at: http://www.innovations.ahrq.gov/resources/InnovationAdoptionGuide.pdf

“…The Guide helps users determine if an innovation would be a good fit—or an appropriate stretch—for their health care organization by asking a series of questions. It links users to actionable Web-based tools and presents case studies that illustrate how other organizations have addressed these questions. Users will be able to answer the four overarching questions the Guide poses:

- Does this innovation fit?

- Should we do it here?

- Can we do it here?

- How can we do it here?...”

Contents

Purpose

How to Use the Guide

Module I: Does the Innovation Fit?

What Is the Innovation?

Does It Further Our Goals?

Is It Compatible With Our Organization?

Module II: Should We Do It Here?

What Are the Potential Benefits?

What Are the Potential Costs ?

Can We Build a Business Case?

What Are the Risks ?

Module III: Can We Do It Here

Are We Ready for This Change ?

What Changes Will We Have to Make ?

Do We Have the Ingredients for Success ?

Module IV: How Will We Do It Here

How Will We Measure the Impact of the Innovation ?

Can We Try the Innovation First ?

How Will We Implement the Innovation ?

Index of Tools

References

Appendix: Case Study Report

Investigators

Cindy Brach, Nancy Lenfestey, Amy Roussel, Jacqueline Amoozegar, Asta Sorensen

Using Logic Models to Bring Together Planning, Evaluation, and Action

Logic Model Development Guide

W.K. Kellogg Foundation

PDF [72p.] at: http://www.wkkf.org/Pubs/Tools/Evaluation/Pub3669.pdf

The Informed Decisions Toolbox

http://toolbox.berkeley.edu/tools/

* * *

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.

[EQ] Introduction to Evidence-Informed Public Health and A Compendium of Critical Appraisal Tools for Public Health Practice

Introduction to Evidence-Informed Public Health and a Compendium of Critical Appraisal Tools for Public Health Practice

National Collaborating Centre for Methods and Tools (NCCMT)

McMaster University, Hamilton, Ontario - Public Health Agency of Canada - 2008

PDF file at: http://www.nccmt.ca/pubs/eiph_backgrounder.pdf

This background paper defines and summarizes the concept of Evidence-Informed Public Health.
The paper also includes a compendium of critical appraisal tools to help you incorporate the best research evidence into public health practice and policy development.

Background paper: English Version [PDF, 398Kb] Version française [PDF, 417Kb]
Compendium: English Version [PDF, 301Kb] Version française [PDF, 306Kb]

Can I use this evidence in my program decision? Assessing Applicability and Transferability of Evidence

This paper summarizes the current literature and provides a process for evaluating the feasibility and generalizability of evidence to public health practice. A tool was then developed to help public health managers and planners in making decisions about program priorities in their communities

English Version [PDF, 100Kb] Version française [PDF, 100Kb]

* * *

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.